| scholarly article | Q13442814 |
| P50 | author | Bente Klarlund Pedersen | Q12303219 |
| Milena Penkowa | Q3378367 | ||
| Christian Erikstrup | Q63748764 | ||
| Birgitte Lindegaard | Q42259968 | ||
| Christian P. Fischer | Q44013919 | ||
| Peter Plomgaard | Q54574972 | ||
| Ole Hartvig Mortensen | Q56587895 | ||
| P2093 | author name string | R Krogh-Madsen | |
| C Broholm | |||
| A M W Petersen | |||
| A R Nielsen | |||
| S Taudorf | |||
| P2860 | cites work | Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans | Q61788681 |
| Interrelationships between muscle morphology, insulin action, and adiposity | Q71418567 | ||
| Muscle fiber composition and capillary density in women and men with NIDDM | Q72133555 | ||
| Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo | Q73278748 | ||
| No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients | Q73555653 | ||
| Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus | Q78157606 | ||
| Resistance training alters cytokine gene expression in skeletal muscle of adults with type 2 diabetes | Q79430813 | ||
| TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue--influence of BMI and adipose distribution | Q79751872 | ||
| Proteolytic mRNA expression in response to acute resistance exercise in human single skeletal muscle fibers | Q79903258 | ||
| Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study | Q79986532 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Use and abuse of HOMA modeling | Q28263292 | ||
| Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance | Q29012156 | ||
| IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance | Q29619774 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| Percutaneous needle biopsy of skeletal muscle in physiological and clinical research | Q34084383 | ||
| Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials | Q34370728 | ||
| Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans | Q34444458 | ||
| Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1 | Q34449273 | ||
| Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus | Q34541876 | ||
| Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes | Q35677410 | ||
| Role of cytokines in inducing hyperlipidemia | Q35840939 | ||
| The expression of TNF alpha by human muscle. Relationship to insulin resistance | Q37352139 | ||
| Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans | Q39236095 | ||
| TNF induces internalization of the p60 receptor and shedding of the p80 receptor | Q41475994 | ||
| TNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone | Q42446456 | ||
| Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. | Q42462340 | ||
| Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity | Q42467211 | ||
| Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity | Q42814772 | ||
| Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation | Q43699235 | ||
| Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus | Q43908172 | ||
| Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. | Q44916891 | ||
| Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors | Q45161618 | ||
| Skeletal muscle inflammation and nitric oxide in patients with COPD. | Q46681318 | ||
| Is Type II diabetes mellitus a disease of the innate immune system? | Q48364597 | ||
| Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus | Q51549607 | ||
| Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. | Q51555311 | ||
| Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. | Q51580928 | ||
| Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years | Q53951145 | ||
| Serum Levels of Tumor Necrosis Factor-α Are Increased in Obese Patients with Noninsulin-Dependent Diabetes Mellitus1 | Q54144879 | ||
| MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. | Q55042948 | ||
| P433 | issue | 12 | |
| P921 | main subject | insulin resistance | Q1053470 |
| type 2 diabetes | Q3025883 | ||
| TNF | Q18032037 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 2562-2571 | |
| P577 | publication date | 2007-10-10 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes | |
| P478 | volume | 50 |
| Q33630095 | Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet. |
| Q46113676 | An acute bout of endurance exercise but not sprint interval exercise enhances insulin sensitivity |
| Q39443668 | Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease |
| Q93110135 | Association of Tumor Necrosis Factor Alpha, Interleukin 6, and C-Reactive Protein with the Risk of Developing Type 2 Diabetes: A Retrospective Cohort Study of Rural Thais |
| Q33510158 | Calprotectin--a novel marker of obesity |
| Q37335279 | Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. |
| Q35869657 | Circulating Levels of TNF-α Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis Study |
| Q59326150 | Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes |
| Q36517318 | Effect of A One-Week Balanced Diet on Expression of Genes Related to Zinc Metabolism and Inflammation in Type 2 Diabetic Patients. |
| Q35405108 | Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase |
| Q35112048 | Elevated contaminants contrasted with potential benefits of ω-3 fatty acids in wild food consumers of two remote first nations communities in northern Ontario, Canada |
| Q37057674 | Evaluation of Adiposity-Related Biomarkers as Metabolic Syndrome Indicators |
| Q37042484 | Exercise as a mean to control low-grade systemic inflammation |
| Q50594460 | Former male elite athletes have better metabolic health in late life than their controls |
| Q37360466 | Gene profiling of human adipose tissue during evoked inflammation in vivo |
| Q37672251 | Gluteofemoral body fat as a determinant of metabolic health. |
| Q41479479 | High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis. |
| Q50000860 | High fat diet sensitizes fibromyalgia-like pain behaviors in mice via tumor necrosis factor alpha. |
| Q53509656 | Histopathological changes in rat pancreas and skeletal muscle associated with high fat diet induced insulin resistance |
| Q38332114 | Impact of gestational diabetes mellitus in the maternal-to-fetal transport of nutrients |
| Q28267473 | In-depth analysis of the human tear proteome |
| Q37255877 | Inflamed adipose tissue, insulin resistance and vascular injury |
| Q46165782 | Insulin resistance without obesity induced by cotton pellet granuloma in mice |
| Q37357299 | Insulin sensitivity in African-American and white women: association with inflammation |
| Q36412755 | Interaction between cytokine gene polymorphisms and the effect of physical exercise on clinical and inflammatory parameters in older women: study protocol for a randomized controlled trial. |
| Q37224431 | Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance |
| Q33574967 | Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes |
| Q43206562 | Liver-specific reduction of Mfn2 protein by RNAi results in impaired glycometabolism and lipid homeostasis in BALB/c mice |
| Q92617368 | Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality |
| Q37253051 | Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems |
| Q47151149 | Organ-specific alterations in circadian genes by vertical sleeve gastrectomy in an obese diabetic mouse model |
| Q33803847 | Pentoxifylline decreases glycemia levels and TNF-alpha, iNOS and COX-2 expressions in diabetic rat pancreas |
| Q64241093 | Physical Activity and Bone Health: What Is the Role of Immune System? A Narrative Review of the Third Way |
| Q36943769 | Plasma YKL-40: a BMI-independent marker of type 2 diabetes |
| Q34277885 | Plasma and muscle myostatin in relation to type 2 diabetes |
| Q45780173 | Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation |
| Q82299568 | Potential role of selected biomarkers for predicting the presence and extent of coronary artery disease |
| Q35803575 | Protective effect of pretreatment with propofol against tumor necrosis factor-α-induced hepatic insulin resistance |
| Q37821109 | Reactive oxygen species and insulin resistance: the good, the bad and the ugly |
| Q41772617 | Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses |
| Q23921425 | Residential Black Carbon Exposure and Circulating Markers of Systemic Inflammation in Elderly Males: The Normative Aging Study |
| Q47173280 | Resistance exercise training-induced decrease in circulating inflammatory CD14+CD16+ monocyte percentage without weight loss in older adults. |
| Q33710086 | Role of PGC-1α in exercise training- and resveratrol-induced prevention of age-associated inflammation |
| Q34326387 | Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. |
| Q34082809 | Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans |
| Q26865663 | Something old, something new and something very old: drugs for treating type 2 diabetes |
| Q38584502 | Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes |
| Q37435676 | Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity |
| Q33567573 | The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS) |
| Q33746430 | The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans |
| Q44787749 | The association of type 2 diabetes and insulin resistance/secretion with persistent organic pollutants in two First Nations communities in northern Ontario |
| Q35387157 | The contribution of vitamin A to autocrine regulation of fat depots. |
| Q45261661 | The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes |
| Q51163690 | The role of TNF-α G-308A promoter polymorphism in glycemic control in Type 2 diabetes patients |
| Q21296864 | The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases |
| Q38317361 | Vanadium compounds modulate PPARγ activity primarily by increasing PPARγ protein levels in mouse insulinoma NIT-1 cells |
Search more.